Cui et al., 2020 - Google Patents
Pirfenidone inhibits cell proliferation and collagen I production of primary human intestinal fibroblastsCui et al., 2020
View HTML- Document ID
- 6984814563392063536
- Author
- Cui Y
- Zhang M
- Leng C
- Blokzijl T
- Jansen B
- Dijkstra G
- Faber K
- Publication year
- Publication venue
- Cells
External Links
Snippet
Intestinal fibrosis is a common complication of inflammatory bowel disease. So far, there is no safe and effective drug for intestinal fibrosis. Pirfenidone is an anti-fibrotic compound available for the treatment of idiopathic pulmonary fibrosis. Here, we explored the anti …
- 229960003073 Pirfenidone 0 title abstract description 153
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cui et al. | Pirfenidone inhibits cell proliferation and collagen I production of primary human intestinal fibroblasts | |
| Gong et al. | Vanillic acid suppresses HIF-1α expression via inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK pathways in human colon cancer HCT116 cells | |
| Ebrahim et al. | Mesenchymal stem cell-derived exosomes ameliorated diabetic nephropathy by autophagy induction through the mTOR signaling pathway | |
| Smith-Cortinez et al. | Simultaneous induction of glycolysis and oxidative phosphorylation during activation of hepatic stellate cells reveals novel mitochondrial targets to treat liver fibrosis | |
| Moonen et al. | Epithelial cell cycle behaviour in the injured kidney | |
| Fang et al. | IgE downregulates PTEN through microRNA-21-5p and stimulates airway smooth muscle cell remodeling | |
| Wu et al. | Osteoarthritic subchondral bone release exosomes that promote cartilage degeneration | |
| Čipak Gašparović et al. | Chronic oxidative stress promotes molecular changes associated with epithelial mesenchymal transition, NRF2, and breast cancer stem cell phenotype | |
| Wang et al. | Characterization of the roles of vimentin in regulating the proliferation and migration of HSCs during hepatic fibrogenesis | |
| Patel et al. | Insights into the regulation of ciliary disassembly | |
| Duijkers et al. | Antisense oligonucleotide-based splicing correction in individuals with leber congenital amaurosis due to compound heterozygosity for the c. 2991+ 1655A> G mutation in CEP290 | |
| Al Bitar et al. | Thymoquinone radiosensitizes human colorectal cancer cells in 2D and 3D culture models | |
| Cho et al. | Repression of transcriptional activity of forkhead box O1 by histone deacetylase inhibitors ameliorates hyperglycemia in type 2 diabetic rats | |
| Park et al. | The role of extracellular vesicles in optic nerve injury: neuroprotection and mitochondrial homeostasis | |
| Di Maio et al. | Evaluation of browning agents on the white adipogenesis of bone marrow mesenchymal stromal cells: A contribution to fighting obesity | |
| Lee | Therapeutic potential of the combination of pentoxifylline and vitamin-E in inflammatory bowel disease: Inhibition of intestinal fibrosis | |
| Sriratanasak et al. | Cisplatin induces senescent lung cancer cell-mediated stemness induction via GRP78/Akt-dependent mechanism | |
| Yu et al. | Repeated administration of cisplatin transforms kidney fibroblasts through G2/M arrest and cellular senescence | |
| Esa et al. | The role of methionine aminopeptidase 2 in lymphangiogenesis | |
| Gramignoli et al. | Effects of pro-inflammatory cytokines on hepatic metabolism in primary human hepatocytes | |
| Jang et al. | Curcumin disrupts a positive feedback loop between ADMSCs and cancer cells in the breast tumor microenvironment via the CXCL12/CXCR4 axis | |
| Claveria-Cabello et al. | Dual pharmacological targeting of HDACs and PDE5 inhibits liver disease progression in a mouse model of biliary inflammation and fibrosis | |
| Simao et al. | The activation of the NF-κB pathway in human adipose-derived stem cells alters the deposition of epigenetic marks on H3K27 and is modulated by fish oil | |
| Jankó et al. | Silencing of poly (ADP-ribose) polymerase-2 induces mitochondrial reactive species production and mitochondrial fragmentation | |
| Almanzar et al. | 5-FU-miR-15a inhibits activation of pancreatic stellate cells by reducing YAP1 and BCL-2 levels in vitro |